How does Egrifta work to reduce stomach fat in people with HIV?

Advertisement
Advertisement
Egrifta (tesamorelin) works to reduce stomach fat in people infected with HIV by stimulating the release of human growth hormones. (Some people with HIV develop a condition called lipodystrophy, which causes fat to accumulate in their abdomen.) These hormones reduce the amount of abdominal fat surrounding internal organs, reducing the size of the abdomen. Egrifta does not cause overall weight loss.

Continue Learning about Endocrine-Metabolic Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.